Aubagio

Teriflunomide

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Adults w/ relapsing remitting multiple sclerosis (MS).

Recommended dose: 14 mg once daily.

May be taken with or without food.

Hypersensitivity. Severe immunodeficiency states (eg, AIDS). Significantly impaired bone marrow function or significant anaemia, leucopenia, neutropenia or thrombocytopenia. Severe active infection until resolution. Severe hypoproteinaemia (eg, in nephrotic syndrome). Severe hepatic impairment (Child-Pugh class C). Severe renal impairment undergoing dialysis. Pregnant or women of childbearing potential who are not using reliable contraception during treatment & thereafter as long as plasma levels are >0.02 mg/L. Lactation.

Immunosuppressants

L04AK02 - teriflunomide ; Belongs to the class of dihydroorotate dehydrogenase (DHODH) inhibitors. Used as immunosuppressants.

POM